Bharat Immunologicals (India) News

Macroaxis does not monitor all media channels or aggregates social signals for Bharat Immunologicals. But even though we do not provide professional-grade financial sentiment analysis on Bharat Immunologicals, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for Bharat Immunologicals. Check also Trending Equities.

Latest Stories

Recently Published Macroaxis Headlines
Price Growth (%)  


Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

Total Debt

Bharat Immunologicals Total Debt
Based on latest financial disclosure Bharat Immunologicals Biologicals Corp Ltd has Total Debt of 177.56 M. This is much higher than that of the sector, and significantly higher than that of Total Debt industry, The Total Debt for all stocks is over 1000% lower than the firm.
In most industries, total debt may also include current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meaningful to compare total debt amounts between companies that operate within the same sector.